A 6‐day peroral phenobarbital treatment of beagle dogs decreased clearly and significantly the mean AUC (1252±270 ng/ml/hr) of a single peroral dose of nitrazepam (1.5 mg/kg), as a sign of enzyme induction to one third (428 ±37 ng/ml/hr P<0.05) in plasma and the concentration maximum (Cmax) (301± 62 ng/ml/hr) to one third (110±15 ng/ml/hr, P<0.05), respectively. The mean Kel, 0.36±0.04, increased to 0.54±0.04 (P<0.05), respectively. An 11‐day phenobarbital treatment decreased the mean AUC of nitrazepam further to one sixth (197±41 ng/ml/hr, P<0.01) and the Cmax to one fifth (65±10 ng/ml/hr, P<0.01), while the mean Kel increased from 0.36±0.04 to 0.65±0.02 (P<0.001). The 12‐day peroral nitrazepam treatment showed no sign of autoinduction as a single daily dose. The mean AUC of a single nitrazepam dose of the 1st day. 1290 ± 256 ng/ml/hr increased after the 24‐day nitrazepam treatment, to 3617±202 ng/ml/hr and after the 61‐day treatment to 3379±321 ng/ml/hr. The mean maximum concentration (Cmax), 343±69 ng/ml/hr, increased to 727±52 ng/ml/hr, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.